Zobrazeno 1 - 4
of 4
pro vyhledávání: '"35"'
Autor:
Isamu Okamoto, Tatsuo Ohira, Nobuyuki Yamamoto, Hidehito Horinouchi, Toyoaki Hida, Shinji Atagi, Tatsuro Fukuhara, Miyako Satouchi, Kazuma Kishi, Shunichi Sugawara, Shi Rong Han, Hideo Saka, Victoria Ebiana, Katsuyuki Hotta, Keisuke Aoe, Kazuhiko Nakagawa, Hiroshi Sakai, Hiroaki Okamoto, Kazuo Noguchi, Kaname Nosaki, Atsushi Horiike, Shigeki Umemura, Toshiaki Takahashi, Takayasu Kurata, Nobuyuki Katakami, Akimasa Sekine
Publikováno v:
Cancer Science
Cancer Sci
Cancer Sci
This prespecified subanalysis of the global, randomized controlled phase III KEYNOTE‐024 study of pembrolizumab vs chemotherapy in previously untreated metastatic non‐small‐cell lung cancer without EGFR/ALK alterations and a programmed death li
Publikováno v:
Cancer Medicine, Vol 10, Iss 9, Pp 3035-3044 (2021)
Cancer Medicine
Cancer Medicine
The application of positron emission tomography (PET)‐computed tomography (CT) in treatment response evaluation has increased in diffuse large B‐cell lymphoma (DLBCL), although its predictive value is controversial. We retrospectively analyzed th
Autor:
Kengo Takeuchi, Ukihide Tateishi, Tetsuya Mori, Akiko Saito, Ilseung Choi, Akiko Kada, Takashi Terauchi, Reiji Fukano, Ryuta Asada, Masahiro Sekimizu, Keizo Horibe, Hirokazu Nagai
Publikováno v:
Cancer Science
Anaplastic lymphoma kinase (ALK) inhibition is expected to be a promising therapeutic strategy for ALK‐positive malignancies. We aimed to examine the efficacy and safety of alectinib, a second‐generation ALK inhibitor, in patients with relapsed o
Autor:
Matthew J. Ehrhardt, Kirsten K. Ness, Matthew J. Krasin, Wayne L. Furman, Leslie L. Robison, Melissa M. Hudson, Daniel M. Green, Sujuan Huang, Nickhill Bhakta, Tara M. Brinkman, Carmen L. Wilson, Geehong Hyun, Cathleen Marie Cook
Publikováno v:
Cancer
BACKGROUND The objective of this study was to characterize chronic disease, health-related quality of life (HRQOL), emotional distress, and social attainment among long-term survivors of neuroblastoma. METHODS Chronic health conditions among 136 ≥1